U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H21NO.ClH
Molecular Weight 303.826
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AZACYCLONOL HYDROCHLORIDE

SMILES

Cl.OC(C1CCNCC1)(C2=CC=CC=C2)C3=CC=CC=C3

InChI

InChIKey=LBRAWKGGVUCSOX-UHFFFAOYSA-N
InChI=1S/C18H21NO.ClH/c20-18(15-7-3-1-4-8-15,16-9-5-2-6-10-16)17-11-13-19-14-12-17;/h1-10,17,19-20H,11-14H2;1H

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C18H21NO
Molecular Weight 267.3654
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Azacyclonol (aka gamma-pipradrol) is an ataractive agent; a compound which diminished hallucinations in psychotic individuals. It is sometimes referred to as a tranquilizer or antipsychotic, though it does not actually possess these properties. It was used in Europe during the 1950's for treatment of schizophrenia; likely to reduce the psychedelic effects of LSD and mescaline. However, it had mixed clinical effectiveness and did not gain widespread adoption and was eventually discontinued. Azacyclonol was sold under several trade names: Ataractan, Calmeran, Frenoton, Frenquel and Psychosan.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Frenquel

Approved Use

Unknown
Doses

Doses

DosePopulationAdverse events​
400 mg 1 times / day multiple, oral
Studied dose
Dose: 400 mg, 1 times / day
Route: oral
Route: multiple
Dose: 400 mg, 1 times / day
Sources:
unhealthy
Health Status: unhealthy
Sources:
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Hepatobiliary disposition of a drug/metabolite pair: Comprehensive pharmacokinetic modeling in sandwich-cultured rat hepatocytes.
2006-08
The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates.
2006-03
The effect of rifampin administration on the disposition of fexofenadine.
2001-03
Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers.
1999-05
THE HYPOGLYCAEMIC EFFECT OF AZACYCLONOL AND ITS MECHANISM.
1963-10-01
[Azacyclonol (Frenquel). Uses and results].
1960-10
Azacyclonol in chronic schizophrenia.
1959-09-01
Intravenous use of azacyclonol.
1958-05
Azacyclonol (frenquel) hydrochloride in the treatment of chronic schizophrenia; a double-blind, controlled study.
1957-09-28
Patents

Sample Use Guides

Chronic Schizophrenics were treated for four weeks with daily oral doses of 20 mg Frenquel to control the hallucinogenic effects of LSD. Twenty-one of thirty-eight patients showed definite improvements, while seven more showed doubtful-improvement. Frenquel was also used in oral doses of up to 400 mg daily.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:49:13 GMT 2025
Edited
by admin
on Mon Mar 31 17:49:13 GMT 2025
Record UNII
4BXX0XNP9R
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FRENQUEL
Preferred Name English
AZACYCLONOL HYDROCHLORIDE
MART.   MI   WHO-DD  
Common Name English
ALPHA.,.ALPHA.-DIPHENYL-4-PIPERIDINEMETHANOL, HYDROCHLORIDE
Common Name English
Azacyclonol hydrochloride [WHO-DD]
Common Name English
AZACYCLONOL HYDROCHLORIDE [MI]
Common Name English
AZACYCLONOL HCL
Common Name English
AZACYCLONOL HYDROCHLORIDE [MART.]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C28197
Created by admin on Mon Mar 31 17:49:13 GMT 2025 , Edited by admin on Mon Mar 31 17:49:13 GMT 2025
Code System Code Type Description
EPA CompTox
DTXSID90170867
Created by admin on Mon Mar 31 17:49:13 GMT 2025 , Edited by admin on Mon Mar 31 17:49:13 GMT 2025
PRIMARY
MERCK INDEX
m575
Created by admin on Mon Mar 31 17:49:13 GMT 2025 , Edited by admin on Mon Mar 31 17:49:13 GMT 2025
PRIMARY Merck Index
FDA UNII
4BXX0XNP9R
Created by admin on Mon Mar 31 17:49:13 GMT 2025 , Edited by admin on Mon Mar 31 17:49:13 GMT 2025
PRIMARY
EVMPD
SUB00635MIG
Created by admin on Mon Mar 31 17:49:13 GMT 2025 , Edited by admin on Mon Mar 31 17:49:13 GMT 2025
PRIMARY
ChEMBL
CHEMBL127508
Created by admin on Mon Mar 31 17:49:13 GMT 2025 , Edited by admin on Mon Mar 31 17:49:13 GMT 2025
PRIMARY
ECHA (EC/EINECS)
217-284-9
Created by admin on Mon Mar 31 17:49:13 GMT 2025 , Edited by admin on Mon Mar 31 17:49:13 GMT 2025
PRIMARY
PUBCHEM
15722
Created by admin on Mon Mar 31 17:49:13 GMT 2025 , Edited by admin on Mon Mar 31 17:49:13 GMT 2025
PRIMARY
CAS
1798-50-1
Created by admin on Mon Mar 31 17:49:13 GMT 2025 , Edited by admin on Mon Mar 31 17:49:13 GMT 2025
PRIMARY
NCI_THESAURUS
C76503
Created by admin on Mon Mar 31 17:49:13 GMT 2025 , Edited by admin on Mon Mar 31 17:49:13 GMT 2025
PRIMARY
MESH
C100095
Created by admin on Mon Mar 31 17:49:13 GMT 2025 , Edited by admin on Mon Mar 31 17:49:13 GMT 2025
PRIMARY
SMS_ID
100000085346
Created by admin on Mon Mar 31 17:49:13 GMT 2025 , Edited by admin on Mon Mar 31 17:49:13 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY